Regeneron Pharmaceuticals Inc.
REGN | NASDAQ
$969.42
+$41.53 (+4.48%)
Nov 2, 2026, 12:35 PM ET · Market open
Market Data
Market Cap $99.79B
Enterprise Value $88.94B
Beta 0.24
Average Volume 760.01K
Shares Outstanding (Diluted) 105.6M
Shares Change YoY -1.49%
Institutional Ownership 89.27%
Exchange NASDAQ
ISIN US75886F1075
Price Performance
Price Change 1M 31.9%
Price Change 3M 27.7%
Price Change 6M 36.7%
Price Change YTD 25.6%
Price Change 1Y 50.9%
Price Change 3Y 18.7%
Price Change 5Y 48.7%
1M CAGR (ann.) 18.2%
1Y CAGR (ann.) 42.9%
5Y CAGR (ann.) 10.3%
All-Time CAGR 9.9%
Valuation
PE Ratio 20.50
Forward PE 13.30
PEG Ratio 2.45
Forward PEG 0.52
PS Ratio 5.65
Forward PS 4.90
PB Ratio 2.85
P/FCF Ratio 26.63
P/Adj. FCF Ratio 36.99
P/OCF Ratio 20.48
EV/Sales 5.26
EV/EBIT 15.51
EV/EBITDA 14.24
EV/FCF 24.79
Earnings Yield 4.9%
FCF Yield 3.8%
Adj. FCF Yield 2.7%
Financial Health
Net Cash $7.31B
Total Debt $2.71B
Cash & Short-Term Investments $9.3B
Total Assets $44.41B
Current Ratio 3.35
Quick Ratio 2.89
Debt / Equity Ratio 0.08
Debt / EBITDA 0.43
Debt / FCF 0.75
OCF / Debt 1.70
Interest Coverage 106.88
Altman Z-Score 7.70
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 85.8%
Operating Profit Margin 29.5%
EBITDA Margin 37.0%
Net Profit Margin 28.5%
FCF Margin 21.2%
Adj. FCF Margin 15.3%
SBC / Revenue 6.0%
SBC Impact (per share) -28.0%
Returns
Return on Assets 10.8%
Return on Equity 15.1%
Return on Invested Capital 10.9%
Return on Capital Employed 13.1%
Return on Tangible Assets 11.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 8.9%
Revenue CAGR 5Y 4.5%
Revenue CAGR 10Y 13.6%
EPS CAGR 3Y 8.9%
EPS CAGR 5Y -6.3%
EPS CAGR 10Y 20.7%
FCF CAGR 3Y -8.0%
FCF CAGR 5Y -7.8%
FCF CAGR 10Y 15.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 24
EPS Growth Next 3Y 20.9%
Revenue Growth Next 3Y 10.7%
Earnings Date Jan 28, 2027
EPS Estimate (next Q) $24.25
EPS Growth Est (next Q) 112.0%
Revenue Est (next Q) $5.75B
Revenue Growth Est (next Q) 48.1%
Fair Value Estimates
Graham Number $579.17
Graham Upside -37.6%
Lynch Fair Value $226.30
Lynch Upside -75.6%
Price Target $859.63
Price Target Upside -7.4%
Cash Flow
Operating Cash Flow $4.61B
Free Cash Flow $3.59B
Adj. Free Cash Flow $2.58B
FCF Per Share $35.28
OCF Per Share $45.30
OCF/S Ratio 27.3%
Income Statement
Revenue $16.9B
Gross Profit $14.49B
Operating Income $4.99B
EBITDA $6.25B
Net Income $4.82B
EPS (Diluted) $45.26
Revenue / Employee $1.1M
Profit / Employee $312.62K
Employees 15,410
Dividends
Annual Dividend $3.70
Dividend Yield 0.40%
Payout Ratio 8.2%
FCF Payout Ratio 10.7%
Adj. FCF Payout Ratio 14.8%
Dividend Growth (YoY) 40.1%
Pay Frequency Quarterly
Ex-Dividend Date Aug 18, 2026
Add to Watchlist
Select watchlists to add or remove REGN